[1]
2021. Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital. Acta Biomedica Atenei Parmensis. 92, S6 (Oct. 2021), e2021450. DOI:https://doi.org/10.23750/abm.v92iS6.12217.